Can we predict relapse in Graves' disease? Results from a systematic review and meta-analysis.

Author: DegenChristian, FehlbergHannah, GuebelinLarissa, KutzAlexander, MuellerBeat, SchuetzPhilipp, StrujaTristan

Paper Details 
Original Abstract of the Article :
BACKGROUND: Identification of pretreatment risk factors predicting relapse in patients with hyperthyroidism of Graves' disease after stopping anti-thyroid drugs (ATD) is decisive to guide therapeutic options. PURPOSE: We performed a systematic search and meta-analysis to study predictors for relaps...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1530/EJE-16-0725

データ提供:米国国立医学図書館(NLM)

Predicting Relapse in Graves' Disease: A Quest for Personalized Treatment

This study delves into the complex world of Graves' disease, a condition characterized by hyperthyroidism. The research focuses on identifying pretreatment risk factors that can predict relapse after discontinuing anti-thyroid drugs (ATD). The study analyzed data from 54 trials, encompassing a vast population of individuals with Graves' disease. This comprehensive approach aimed to identify key predictors of relapse, guiding clinicians in making informed treatment decisions.

Unraveling the Predictors of Relapse: A Multifaceted Approach

The study identifies several significant risk factors for relapse, including orbitopathy, smoking, thyroid volume, goiter size, and certain thyroid hormone levels. This information is crucial for tailoring treatment strategies to individual patients, potentially reducing the likelihood of relapse and optimizing treatment outcomes. The study emphasizes the need to consider individual risk factors when managing Graves' disease.

Tailoring Treatment to Individual Needs: A Personalized Approach

The study's findings underscore the importance of personalized medicine in managing Graves' disease. By identifying individual risk factors, clinicians can tailor treatment plans to minimize the risk of relapse. This research emphasizes the need for a holistic approach to treatment, considering both individual characteristics and the potential for disease recurrence.

Dr.Camel's Conclusion

The desert landscape is characterized by unpredictable sandstorms, just as Graves' disease can be unpredictable. This research provides valuable insights into the factors that can influence relapse, allowing healthcare professionals to navigate the complexities of this condition with greater precision. By understanding the individual factors that contribute to relapse, we can strive to offer personalized treatments that lead to sustained remission and improved quality of life for those living with Graves' disease.

Date :
  1. Date Completed 2017-02-07
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27780830

DOI: Digital Object Identifier

10.1530/EJE-16-0725

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.